[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA35212B1 - Essai de la lysyl oxydase de type 2 et ses procédés d'utilisation - Google Patents

Essai de la lysyl oxydase de type 2 et ses procédés d'utilisation

Info

Publication number
MA35212B1
MA35212B1 MA36627A MA36627A MA35212B1 MA 35212 B1 MA35212 B1 MA 35212B1 MA 36627 A MA36627 A MA 36627A MA 36627 A MA36627 A MA 36627A MA 35212 B1 MA35212 B1 MA 35212B1
Authority
MA
Morocco
Prior art keywords
assay
lysyl oxidase
methods
oxidase type
type
Prior art date
Application number
MA36627A
Other languages
English (en)
Inventor
Victoria Smith
Joanne I Adamkewicz
Susan K Lyman
Jason Chien
Xiaoming Li
Lixin Shao
Jeffrey D Bornstein
Original Assignee
Gilead Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA35212(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics Inc filed Critical Gilead Biologics Inc
Publication of MA35212B1 publication Critical patent/MA35212B1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)

Abstract

La présente invention concerne un essai pour détecter et/ou quantifier des polypeptides circulants de lysyl oxydase de type 2 (loxl2) dans un individu. Selon l'invention, l'essai est utile également dans des applications de diagnostic ou de pronostic.
MA36627A 2011-06-01 2013-12-30 Essai de la lysyl oxydase de type 2 et ses procédés d'utilisation MA35212B1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21
PCT/US2012/040585 WO2012167181A1 (fr) 2011-06-01 2012-06-01 Essai de la lysyl oxydase de type 2 et ses procédés d'utilisation

Publications (1)

Publication Number Publication Date
MA35212B1 true MA35212B1 (fr) 2014-06-02

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36627A MA35212B1 (fr) 2011-06-01 2013-12-30 Essai de la lysyl oxydase de type 2 et ses procédés d'utilisation

Country Status (25)

Country Link
US (3) US20140206017A1 (fr)
EP (1) EP2714744A1 (fr)
JP (3) JP2014523521A (fr)
KR (1) KR20140048156A (fr)
CN (1) CN103946241A (fr)
AP (1) AP2013007285A0 (fr)
AR (1) AR086657A1 (fr)
AU (2) AU2012261883A1 (fr)
BR (1) BR112013030682A2 (fr)
CA (1) CA2837534A1 (fr)
CL (1) CL2013003445A1 (fr)
CO (1) CO6940375A2 (fr)
CR (1) CR20130657A (fr)
EA (1) EA201391627A1 (fr)
EC (1) ECSP13013092A (fr)
IL (1) IL229631A0 (fr)
MA (1) MA35212B1 (fr)
MD (1) MD20130098A2 (fr)
MX (1) MX2013013905A (fr)
PE (1) PE20141450A1 (fr)
PH (1) PH12013502490A1 (fr)
TW (1) TW201319572A (fr)
UY (1) UY34115A (fr)
WO (1) WO2012167181A1 (fr)
ZA (1) ZA201308812B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
JP5312459B2 (ja) 2007-08-02 2013-10-09 ジリード バイオロジクス，インク． Ｌｏｘおよびｌｏｘｌ２阻害剤ならびにこれらの使用
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
WO2011022667A2 (fr) 2009-08-21 2011-02-24 Arresto Biosciences, Inc Domaines catalytiques provenant de la lysyle oxydase et de loxl2
RU2015108348A (ru) 2010-02-04 2015-07-20 Джилид Байолоджикс, Инк. Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения
JP2016500700A (ja) * 2012-10-30 2016-01-14 ギリアード サイエンシーズ， インコーポレイテッド リシルオキシダーゼ様２（ｌｏｘｌ２）に関する治療および診断方法
US20150342943A1 (en) 2014-06-03 2015-12-03 Gilead Sciences, Inc. Methods of treating liver disease
BR112016028750A2 (pt) * 2014-06-11 2017-11-14 Gilead Sciences Inc ?métodos para tratar, prevenir, ou melhorar pelo menos um sintoma associado e para diagnosticar e monitorar insuficiência cardíaca ou fibrilação atrial, inibidor da lisil oxidase ativa ou proteína lisil tipo oxidase, e, composição?
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
EP3423057A1 (fr) 2016-03-04 2019-01-09 Gilead Sciences, Inc. Compositions et combinaisons d'inhibiteurs de l'autotaxine
CA3019003A1 (fr) 2016-04-08 2017-10-12 Gilead Sciences, Inc. Compositions et methodes de traitement du cancer, de maladies inflammatoires et de maladies autoimmunes
GB201704206D0 (en) 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
WO2023091479A1 (fr) * 2021-11-17 2023-05-25 AmMax Bio, Inc. Détection et traitement de la fibrose pulmonaire idiopathique

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
JP5312459B2 (ja) * 2007-08-02 2013-10-09 ジリード バイオロジクス，インク． Ｌｏｘおよびｌｏｘｌ２阻害剤ならびにこれらの使用
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
US20110044981A1 (en) * 2009-08-21 2011-02-24 Spangler Rhyannon Methods and compositions for treatment of pulmonary fibrotic disorders
RU2015108348A (ru) * 2010-02-04 2015-07-20 Джилид Байолоджикс, Инк. Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения
JP5934786B2 (ja) * 2011-05-10 2016-06-15 ボーグワーナー インコーポレーテッド 可変タービン形状を有するターボチャージャ

Also Published As

Publication number Publication date
CN103946241A (zh) 2014-07-23
EP2714744A1 (fr) 2014-04-09
EA201391627A1 (ru) 2014-08-29
JP2014523521A (ja) 2014-09-11
CL2013003445A1 (es) 2014-07-25
AR086657A1 (es) 2014-01-15
AU2016244254A1 (en) 2016-11-03
AU2012261883A1 (en) 2013-05-02
TW201319572A (zh) 2013-05-16
CO6940375A2 (es) 2014-05-09
UY34115A (es) 2013-01-03
AU2016244254B2 (en) 2018-10-18
CR20130657A (es) 2014-05-16
MX2013013905A (es) 2014-05-14
IL229631A0 (en) 2014-01-30
ECSP13013092A (es) 2014-08-29
ZA201308812B (en) 2014-08-27
MD20130098A2 (ro) 2014-06-30
KR20140048156A (ko) 2014-04-23
US20140206017A1 (en) 2014-07-24
PH12013502490A1 (en) 2014-01-20
US20170269085A1 (en) 2017-09-21
JP2016164578A (ja) 2016-09-08
PE20141450A1 (es) 2014-11-06
BR112013030682A2 (pt) 2016-12-06
AP2013007285A0 (en) 2013-11-30
NZ618682A (en) 2016-04-29
WO2012167181A1 (fr) 2012-12-06
US20120309020A1 (en) 2012-12-06
CA2837534A1 (fr) 2012-12-06
JP2018049033A (ja) 2018-03-29

Similar Documents

Publication Publication Date Title
MA35212B1 (fr) Essai de la lysyl oxydase de type 2 et ses procédés d'utilisation
MX2013001042A (es) Biomarcadores de cancer pancreatico y usos de los mismos.
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ705411A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MA34263B1 (fr) Marqueurs de prédiction utiles dans traitement du syndrome de l'x fragile (fxs)
NZ700695A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2013033629A3 (fr) Méthodes et compositions pour le traitement et le diagnostic du cancer colorectal
EA201992748A1 (ru) Диагностические анализы для обнаружения, количественного определения и/или отслеживания микроорганизмов и других аналитов
NZ594751A (en) Method of diagnosis of infection by mycobacteria and reagents therefor
NZ629703A (en) Methods and compositions for detecting multiple analytes with a single signal
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
EP4220158A3 (fr) Dispositif d'analyse d'échantillon d'urine et procédé d'analyse d'échantillon d'urine
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2014006118A (es) Deteccion de analitos.
EA201370070A1 (ru) СПОСОБ ДЕТЕКЦИИ, ДИФФЕРЕНЦИАЦИИ И КВАНТИФИКАЦИИ ПОПУЛЯЦИЙ Т-КЛЕТОК С ИСПОЛЬЗОВАНИЕМ КОЛИЧЕСТВЕННОЙ ПЦР С ОБРАТНОЙ ТРАНСКРИПЦИЕЙ В РЕАЛЬНОМ ВРЕМЕНИ (ОТ-колПЦР РВ)
WO2011021041A3 (fr) Dosage pronostique de détermination de la survie
ATE533855T1 (de) Testverfahren zum nachweis lebensfähiger mikrobenzellen in einer probe
WO2015059487A3 (fr) Détection de l'activité de coupure d'une enzyme
MX336940B (es) Uso de compuestos mejoradores de señal en deteccion de electroquimioluminiscencia.
WO2012139052A3 (fr) Biomarqueurs d'anticorps pour le diabète
GB201021509D0 (en) Assay method
WO2011130647A3 (fr) Compositions et méthodes pour la caractérisation d'une myopathie
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011113813A3 (fr) Dosage